1. Corporate Officers - C
2. Canute Scott A

Insider Trading History of Canute Scott A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Canute Scott A since 2011. The trader's CIK number is 1303416. At the time of the last reporting, Canute Scott A was the Executive VP of Outlook Therapeutics, Inc.. (stock ticker symbol OTLK). Also see all insider trading activities at Outlook Therapeutics, Inc..

Note that in the past Canute Scott A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Outlook Therapeutics, Inc. (ONS) by Canute Scott A

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2016	ONS	0	$0	0	$0	57,971	$0

Yearly summary of insider trading at Genzyme Corp (GENZ) by Canute Scott A

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2011	GENZ	0	$0	0	$0	25,000	$0

Insider trading activities at 2 companies by Canute Scott A:

1. Outlook Therapeutics, Inc. (ONS)

2. Genzyme Corp (GENZ)

Table 1. Insider trading of Outlook Therapeutics, Inc. (ONS) by Canute Scott A

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2016-11-09	ONS	Option Ex	57,971	.00	0

Table 2. Insider trading of Genzyme Corp (GENZ) by Canute Scott A

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2011-04-04	GENZ	Option Ex	25,000	.00	0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Canute Scott A (Executive VP of Outlook Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month